For Cadila Healthcare's Pankaj Patel, Patents Are Key to Growth

For Cadila Healthcare's Pankaj Patel, the pure generics game is a potential 'value destroyer'. Indian pharma companies must focus on developing their own patented drugs, he says

(A link to this page will be included in your message)


Email

Your Name
Required
Email Address
Required
 Send me a copy
Recipient's Email Address
Required
Separate multiple email addresses with commas (max 20)
Your Message
(1000 characters max)
"The details you provide on this page will not be used to send unsolicited e-mail, and will not be sold to a 3rd party."